Our Network of Board-Certified Providers
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
GLP-1 (glucagon-like peptide-1) receptor agonists are FDA-approved prescription medications for weight management and type 2 diabetes. Medications including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda) are now accessible through confidential online telehealth — meaning you never have to discuss your weight or health goals in a crowded waiting room or with someone you know.
Clinical trials demonstrate 15-22% average body weight reduction with semaglutide and tirzepatide over 68-72 weeks. Patients achieve these results quietly, at home, with discreet medication delivery and private physician follow-up — entirely on their own terms.[1][2]
Medically reviewed by
Dr. Sarah Mitchell, MD, ABOM
Board-Certified in Obesity Medicine • Last reviewed: June 5, 2026
Your telehealth consultation is conducted through a fully HIPAA-compliant, private platform. No one in your household, workplace, or community needs to know. Your medical records are encrypted and never shared.
Your FDA-approved GLP-1 medication — semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), or liraglutide (Saxenda) — ships in plain, unmarked packaging. No labels, no pharmacy branding, just your medication.
Your board-certified physician maintains strict confidentiality and treats your health information with the same discretion as any physician-patient relationship. Your GLP-1 journey is private and protected.
Three landmark randomized controlled trials in the New England Journal of Medicine form the evidence base for FDA-approved GLP-1 weight management medications:
Telehealth prescribing of GLP-1 medications is fully legal in all 50 states when conducted by a properly licensed physician through a HIPAA-compliant platform. GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) are not DEA-scheduled controlled substances — no in-person visit is required by federal or state telehealth law.
Adult obesity rates (CDC Behavioral Risk Factor Surveillance System, 2023) vary significantly across the United States. States with higher obesity prevalence experience the greatest demand for accessible GLP-1 telehealth prescriptions:
Source: CDC Behavioral Risk Factor Surveillance System (BRFSS) 2023. Adult obesity defined as BMI ≥ 30.0.
Select your state to access confidential GLP-1 telehealth consultations with licensed physicians. Your privacy is protected in every state.
Patients in major US cities are accessing GLP-1 prescriptions privately online. No waiting rooms, no public clinic visits — just discreet, effective care.
Every step of our process is designed to protect your privacy while delivering the highest quality GLP-1 care.
Complete your health assessment privately from any device — at home, during a lunch break, anywhere. The form is encrypted, HIPAA-compliant, and takes just a few minutes. Your data is never shared with third parties.
Your board-certified physician conducts a private telehealth consultation. This can be asynchronous (messaging-based) or via secure video — entirely on your schedule. No office visits, no receptionists, no public waiting rooms.
Your GLP-1 medication ships from a licensed US pharmacy in plain, unmarked packaging. No medication names, no pharmacy logos on the exterior. Delivered discreetly to your door within 3-5 business days.
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
Yes. All telehealth consultations are conducted through HIPAA-compliant platforms that encrypt your health information and medical records. Your physician is bound by the same confidentiality standards as any in-person doctor. Your health journey stays between you and your physician.
Yes. Medications ship in plain, unmarked boxes with no indication of the contents, the pharmacy name, or any medical branding on the exterior. The only identifying information is your name and delivery address. Your neighbors, family members, or coworkers will not know what is inside.
Your medical records and prescription information are protected by HIPAA. Employers do not have access to your prescription records. If you choose to use insurance, your insurance carrier will have access to billing codes as with any prescription — if you prefer complete privacy, self-pay options are available.
Absolutely. Telehealth prescribing follows the same medical and legal standards as in-person care. Our physicians are board-certified, state-licensed, and conduct full clinical evaluations before prescribing. All medications come from licensed US pharmacies with verifiable authenticity.
Your health data is protected under HIPAA and stored using enterprise-grade encryption. We never sell, share, or market your personal information or health records to third parties. You retain full control over your data and can request deletion at any time.
Black Box Warning: In rodent studies, semaglutide and tirzepatide caused thyroid C-cell tumors. It is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. These medications are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and injection site reactions. These typically diminish as dosage is gradually escalated.
Serious side effects may include pancreatitis, gallbladder problems, kidney injury, hypoglycemia (with insulin), and allergic reactions. Consult your healthcare provider immediately if you experience severe symptoms.
Contraindications: History of medullary thyroid carcinoma, MEN 2, pancreatitis, pregnancy or breastfeeding, severe gastrointestinal disease. This is not a complete list — always discuss your full medical history with your physician.
Clinical References:
